May be unable to keep nxpl price up since its revenue most depends on macroeconomic, but rxmd has reliable and increasing revenue , so if only management or ceo gives a little push pps can be ski rocket or at less maintain a reasonable level. Now shareholders may have more worrisome if they decide to achieve 1 for 1 goal, they may have to make rxmd short fall or substantially lose ... How do you think ?
News 
Market Data 
Discover 
